USD 0.44
(-8.9%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 95.25 Million | 185.34 Million | 121.96 Million | 78.35 Million |
Cost of Revenue | 107.14 Million | 158.5 Million | 109 Million | 82.29 Million |
Gross Profit | -11.88 Million | 26.84 Million | 12.95 Million | -3.93 Million |
Operating Expenses | -42.94 Thousand | 3.26 Million | 2.47 Million | 1.79 Million |
Selling, General and Administrative Expenses | 3.74 Million | 3.26 Million | 2.47 Million | 1.79 Million |
Research and Development Expenses | - | - | - | - |
Other Expenses | -42.94 Thousand | 129.09 Thousand | -100.09 Thousand | 25.48 Thousand |
Cost and Expenses | -42.94 Thousand | 161.76 Million | 111.47 Million | 84.08 Million |
Operating Income | -9.28 Million | 23.58 Million | 10.48 Million | -5.73 Million |
Interest Expense | 112.02 Thousand | 101.87 Thousand | 122.39 Thousand | 60.25 Thousand |
Income Tax Expense | 2542.00 | 11.24 Thousand | 2113.00 | 2357.00 |
Earnings before Tax | -9.32 Million | 23.6 Million | 10.25 Million | -5.75 Million |
Net Income | -9.33 Million | 12.23 Million | 10.25 Million | -5.76 Million |
Earnings Per Share Basic | -0.18 | 0.16 | 0.14 | -0.11 |
Earnings Per Share Diluted | -0.18 | 0.24 | 0.14 | -0.11 |
Weighted Average Shares Outstanding | 52.42 Million | 74.95 Million | 74.95 Million | 52.69 Million |
Weighted Average Shares Outstanding (Diluted) | 52.42 Million | 74.95 Million | 74.95 Million | 52.69 Million |
Gross Margin | -0.12 | 0.14 | 0.11 | -0.05 |
EBIT Margin | -0.10 | 0.13 | 0.09 | -0.07 |
Profit Margin | -0.10 | 0.07 | 0.08 | -0.07 |
EBITDA | -15.57 Million | 23.75 Million | 10.42 Million | -5.65 Million |
Earnings Before Tax Margin | -0.10 | 0.13 | 0.09 | -0.07 |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Revenue | 95.25 Million | - | - | 22.55 Thousand | 22.55 Thousand | 185.34 Million |
Cost of Revenue | 107.14 Million | - | - | 20.85 Thousand | 20.85 Thousand | 158.5 Million |
Gross Profit | -11.88 Million | - | - | 1695.00 | 1695.00 | 26.84 Million |
Operating Expenses | -42.94 Thousand | - | - | 993.87 | 993.87 | 3.26 Million |
Selling, General and Administrative Expenses | - | - | - | 1011.93 | 1011.93 | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -42.94 Thousand | - | - | - | - | 129.09 Thousand |
Cost and Expenses | -42.94 Thousand | - | - | 21.85 Thousand | 21.85 Thousand | 161.76 Million |
Operating Income | -9.28 Million | - | - | 682.32 | 682.32 | 23.58 Million |
Interest Expense | 112.02 Thousand | - | - | - | - | 101.87 Thousand |
Income Tax Expense | 2542.00 | - | - | 305.87 Thousand | 305.87 Thousand | 11.24 Thousand |
Earnings before Tax | -9.32 Million | - | - | 674.85 | 674.85 | 23.6 Million |
Net Income | -9.33 Million | - | - | 368.98 | 368.98 | 12.23 Million |
Earnings Per Share Basic | - | - | - | 0.01 | 0.01 | - |
Earnings Per Share Diluted | - | - | - | 0.01 | 0.01 | - |
Weighted Average Shares Outstanding | 52.42 Million | - | - | 50 Million | 50 Million | 50 Million |
Weighted Average Shares Outstanding (Diluted) | 52.42 Million | - | - | 50 Million | 50 Million | 50 Million |
Gross Margin | -0.12 | - | - | 0.08 | 0.08 | 0.14 |
EBIT Margin | - | - | - | 0.03 | 0.03 | - |
Profit Margin | -0.10 | - | - | 0.02 | 0.02 | 0.07 |
EBITDA | - | - | - | 692.83 | 692.83 | - |
Earnings Before Tax Margin | -0.10 | - | - | 0.03 | 0.03 | 0.13 |
016610
BIOCON
0JSP
601008
8273
PALI